| Robin D Nations, MD | |
|
1020 D A Biglane Dr, Brookhaven, MS 39601-2331 | |
| (601) 823-8000 | |
| (601) 823-7090 |
| Full Name | Robin D Nations |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 32 Years |
| Location | 1020 D A Biglane Dr, Brookhaven, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417932690 | NPI | - | NPPES |
| 00113478 | Medicaid | MS | |
| 050078109 | Other | MS | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 13549 (Mississippi) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 13549 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Center | 3072575539 | 42 |
| Brookhaven Anesthesia And Pain Management | 8123038262 | 4 |
News Archive
More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.
Faster detection and treatment for blood conditions such as anemia has come a step closer with the production of a new device in the UK for medical technology company Entia Ltd.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work in the Liu Laboratory at Augusta University which is studying exosomes where size and concentration are critical parameters.
Women who reported eating diets rich in oils containing alpha-linolenic acid (ALA) seemed to have a lower risk of dying from heart disease and sudden cardiac death than women whose diets are low in the plant-derived fatty acid, researchers reported at the American Heart Association's Scientific Sessions 2004.
› Verified 4 days ago
| Entity Name | Kings Daughters Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043245368 PECOS PAC ID: 3072575539 Enrollment ID: O20041028000174 |
News Archive
More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.
Faster detection and treatment for blood conditions such as anemia has come a step closer with the production of a new device in the UK for medical technology company Entia Ltd.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work in the Liu Laboratory at Augusta University which is studying exosomes where size and concentration are critical parameters.
Women who reported eating diets rich in oils containing alpha-linolenic acid (ALA) seemed to have a lower risk of dying from heart disease and sudden cardiac death than women whose diets are low in the plant-derived fatty acid, researchers reported at the American Heart Association's Scientific Sessions 2004.
› Verified 4 days ago
| Entity Name | Brookhaven Anesthesia & Pain Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689659864 PECOS PAC ID: 8123038262 Enrollment ID: O20060503000513 |
News Archive
More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.
Faster detection and treatment for blood conditions such as anemia has come a step closer with the production of a new device in the UK for medical technology company Entia Ltd.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work in the Liu Laboratory at Augusta University which is studying exosomes where size and concentration are critical parameters.
Women who reported eating diets rich in oils containing alpha-linolenic acid (ALA) seemed to have a lower risk of dying from heart disease and sudden cardiac death than women whose diets are low in the plant-derived fatty acid, researchers reported at the American Heart Association's Scientific Sessions 2004.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robin D Nations, MD Po Box 1547, Sedalia, MO 65302-1547 Ph: (660) 826-5960 | Robin D Nations, MD 1020 D A Biglane Dr, Brookhaven, MS 39601-2331 Ph: (601) 823-8000 |
News Archive
More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.
Faster detection and treatment for blood conditions such as anemia has come a step closer with the production of a new device in the UK for medical technology company Entia Ltd.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work in the Liu Laboratory at Augusta University which is studying exosomes where size and concentration are critical parameters.
Women who reported eating diets rich in oils containing alpha-linolenic acid (ALA) seemed to have a lower risk of dying from heart disease and sudden cardiac death than women whose diets are low in the plant-derived fatty acid, researchers reported at the American Heart Association's Scientific Sessions 2004.
› Verified 4 days ago